Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Nov 6;18(11):e0293942.
doi: 10.1371/journal.pone.0293942. eCollection 2023.

Pareidolias are a function of visuoperceptual impairment

Affiliations

Pareidolias are a function of visuoperceptual impairment

Emily McCann et al. PLoS One. .

Abstract

Pareidolias, or the misperception of ambiguous stimuli as meaningful objects, are complex visual illusions thought to be phenomenologically similar to Visual Hallucination (VH). VH are a major predictor of dementia in Parkinson's Disease (PD) and are included as a core clinical feature in Dementia with Lewy Bodies (DLB). A newly developed Noise Pareidolia Test (NPT) was proposed as a possible surrogate marker for VH in DLB patients as increased pareidolic responses correlated with informant-corroborated accounts of VH. This association could, however, be mediated by visuoperceptual impairment. To understand the drivers of performance on the NPT, we contrasted performances in patient groups that varied both in terms of visuoperceptual ability and rates of VH. N = 43 patients were studied of whom n = 13 had DLB or PD with Dementia (PDD); n = 13 had PD; n = 12 had typical, memory-onset Alzheimer's Disease (tAD); and n = 5 had Posterior Cortical Atrophy (PCA) due to Alzheimer's disease. All patient groups reported pareidolias. Within the Lewy body disorders (PD, DLB, PDD), there was no significant difference in pareidolic response rates between hallucinating and non-hallucinating patients. Visuoperceptual deficits and pareidolic responses were most frequent in the PCA group-none of whom reported VH. Regression analyses in the entire patient cohort indicated that pareidolias were strongly predicted by visuoperceptual impairment but not by the presence of VH. These findings suggest that pareidolias reflect the underlying visuoperceptual impairment of Lewy body disorders, rather than being a direct marker for VH.

PubMed Disclaimer

Conflict of interest statement

The authors have declared that no competing interests exist.

Figures

Fig 1
Fig 1. The composite visuoperception score, and pareidolic responses across patient groups.
Note. The composite visuoperception scores are inverted to positive for ease of comparison to the pareidolia score thus a greater visuoperception z-score corresponds to greater impairment. * p < 0.05; ** p < 0.01; *** p < 0.001; **** p < 0.0001.
Fig 2
Fig 2. Composite visuoperception and pareidolia scores in LBD patients with and without a history of VH.
Fig 3
Fig 3. Spearman’s correlation between visuoperception and pareidolic responses.

References

    1. McKeith IG, Boeve BF, Dickson DW, Halliday GM, Taylor J-P, Weintraub D, et al.. Diagnosis and management of dementia with Lewy bodies Fourth consensus report of the DLB Consortium. Neurology. 2017;89: 88–100. doi: 10.1212/WNL.0000000000004058 - DOI - PMC - PubMed
    1. Aarsland D, Andersen K, Larsen JP, Lolk A, Kragh-Sørensen P. Prevalence and characteristics of dementia in Parkinson disease: An 8-year prospective study. Arch Neurol. 2003;60: 387–392. doi: 10.1001/archneur.60.3.387 - DOI - PubMed
    1. Perry EK, Kerwin J, Perry RH, Blessed G, Fairbairn AF. Visual hallucinations and the cholinergic system in dementia. J Neurol Neurosurg Psychiatry. 1990;53: 88. doi: 10.1136/jnnp.53.1.88 - DOI - PMC - PubMed
    1. Sinclair L, Brenton J, Liu AKL, MacLachlan R, Gentleman SM, Love S. Possible Contribution of Altered Cholinergic Activity in the Visual Cortex in Visual Hallucinations in Parkinson’s Disease. J Neuropsychiatry Clin Neurosci. 2022;34: 168–176. doi: 10.1176/appi.neuropsych.21040103 - DOI - PubMed
    1. McKeith IG, Del Ser T, Spano P, Emre M, Wesnes K, Anand R, et al.. Efficacy of rivastigmine in dementia with Lewy bodies: a randomised, double-blind, placebo-controlled international study. The Lancet. 2000;356: 2031–2036. doi: 10.1016/S0140-6736(00)03399-7 - DOI - PubMed

Publication types